National Committee on Vital and Health Statistics: Meeting; Privacy, Security & Confidentiality Subcommittee, 22209-22210 [2015-09187]
Download as PDF
Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015–09079 Filed 4–20–15; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Request for Comments on Deliberation
and Bioethics Education
Department of Health and
Human Services, Office of the Secretary,
Presidential Commission for the Study
of Bioethical Issues.
ACTION: Notice.
AGENCY:
The Presidential Commission
for the Study of Bioethical Issues is
requesting public comment on
deliberation and bioethics education.
DATES: To ensure consideration,
comments must be received by July 20,
2015. Comments received after this date
will be considered only as time permits.
ADDRESSES: Individuals, groups, and
organizations interested in commenting
on this topic may submit comments by
email to info@bioethics.gov or by mail to
the following address: Public
Commentary, Presidential Commission
for the Study of Bioethical Issues, 1425
New York Ave. NW., Suite C–100,
Washington, DC 20005.
FOR FURTHER INFORMATION CONTACT:
Hillary Wicai Viers, Communications
Director, Presidential Commission for
the Study of Bioethical Issues.
Telephone: 202–233–3960. Email:
hillary.viers@bioethics.gov. Additional
information may be obtained at https://
www.bioethics.gov.
SUPPLEMENTARY INFORMATION: On
November 24, 2009, the President
established the Presidential Commission
for the Study of Bioethical Issues
(Bioethics Commission) to advise him
on bioethical issues generated by novel
and emerging research in biomedicine
and related areas of science and
technology. The Commission is charged
with identifying and promoting policies
and practices that ensure ethically
responsible conduct of scientific
research and health care delivery.
Undertaking these duties, the
Commission seeks to identify and
examine specific bioethical, legal, and
social issues related to potential
scientific and technological advances;
examine diverse perspectives and
possibilities for international
collaboration on these issues; and
recommend legal, regulatory, or policy
actions as appropriate.
The Bioethics Commission is
considering two overarching themes of
its work, deliberation and education,
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:07 Apr 20, 2015
Jkt 235001
focusing on their symbiotic relationship
as twin pillars of public bioethics.
Democratic deliberation has been a
guiding ethical principle in the
Commission’s work, informing both its
processes and its recommendations. The
Commission also is committed to
supporting bioethics education at all
levels and across disciplines, through its
own pedagogical materials and its
recommendations for improving and
integrating ethics education in a range
of settings. This new project will
explore the relationship between
deliberation and bioethics education
and the importance of public
engagement in the bioethics
conversation. For example, the
Commission’s deliberations not only
advise the U.S. federal government, but
also play a vital role in civic education.
Bioethics education fosters the scientific
and ethical literacy that supports public
deliberation about science, medicine,
public health, and bioethics, and helps
to prepare students for their role as
citizens in understanding different
perspectives on complex issues that are
often the subject of public policy
debates.
At its meeting on November 6, 2014,
the Commission heard from scholars in
education, medical ethics, and political
philosophy, and began its consideration
of the relationship between deliberation
and bioethics education and its own
role in promoting both of these to
advance public understanding of and
engagement with bioethical debates. For
example, in its most recent report,
Ethics and Ebola: Public Health
Planning and Response, the
Commission made recommendations
regarding the importance of public
education and deliberation in preparing
for public health emergencies. The
ethical challenges that emerged in the
U.S. response to the ongoing Ebola
epidemic in western Africa underscore
the need for appropriate forums for
public engagement and debate on the
ethical dimensions of public health
decision making.
The Commission is interested in
receiving comments from individuals,
groups, and professional communities
regarding deliberation and education in
bioethics. The Commission is
particularly interested in receiving
public commentary regarding:
• The role of deliberation and
deliberative methods to engage the
public and inform debate in bioethics;
• Approaches to integrating public
dialogue into the bioethics conversation;
• Bioethics education as a forum for
fostering deliberative skills and
preparing students to participate in
public dialogue in bioethics;
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
22209
• Goals of bioethics education (e.g.,
empirical training, normative
foundations, clinical ethics), and the
competencies and skills bioethics
education seeks to foster;
• Methods and goals of designing
bioethics education and training
programs at different levels (e.g.,
undergraduate foci, master’s degree
programs, terminal degree programs,
and professional certification);
• Potential training in bioethics
across the lifespan at different
educational levels and settings (e.g.,
primary/secondary education,
community education, continuing
professional education), and the role of
education in laying the foundation for
constructive public deliberation and
debate in bioethics;
• The appropriate role of professional
standards for bioethicists, including
core competencies for bioethicists, and
potential accreditation of bioethics
training or education programs;
• Integrating bioethics education
across different professional contexts,
and establishing ‘‘dual competency’’
through reciprocal training in bioethics
and a home or primary discipline (e.g.,
engineering and bioethics, medicine and
bioethics, law and bioethics).
To this end, the Commission is
inviting interested parties to provide
input and advice through written
comments. Comments will be publicly
available, including any personally
identifiable or confidential business
information that they contain. Trade
secrets should not be submitted.
Dated: April 13, 2015.
Lisa M. Lee,
Executive Director, Presidential Commission
for the Study of Bioethical Issues.
[FR Doc. 2015–09172 Filed 4–20–15; 8:45 am]
BILLING CODE 4154–06–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Committee on Vital and Health
Statistics: Meeting; Privacy, Security &
Confidentiality Subcommittee
Pursuant to the Federal Advisory
Committee Act, the Department of
Health and Human Services (HHS)
announces the following advisory
committee meeting.
Name: National Committee on Vital
and Health Statistics (NCVHS)
Subcommittee on Privacy,
Confidentiality & Security.
Time And Date: May 6, 2015 9:00
a.m.–5:00 p.m. EST, May 7, 2015 9:00
a.m.–12:00 p.m. EST.
Place: U.S. Department of Health and
Human Services, Centers for Disease
E:\FR\FM\21APN1.SGM
21APN1
22210
Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices
Control and Prevention, National Center
for Health Statistics, 3311 Toledo Road,
Auditorium B and C, Hyattsville,
Maryland 20782, (301) 458–4125.
Status: Open.
Purpose: Section 1179 of the Health
Insurance Portability and
Accountability Act (HIPAA) creates an
exemption from compliance with
HIPAA and accompanying rules when a
financial institution is ‘‘engaged in
authorizing, processing, clearing,
settling, billing, transferring or
collecting payments.’’ The purpose of
this meeting is to learn how banking
and other financial service businesses
are using personal health data as their
services evolve in support of the health
industry.
The objectives of this hearing are as
follows:
Increase awareness of current and
anticipated financial services involving
personal health data, understand section
1179 in light of these practices, and
identify areas where outreach,
education, technical assistance, or
guidance may be useful.
Contact Person For More Information:
Debbie M. Jackson, Acting Executive
Secretary, NCVHS, National Center for
Health Statistics, Centers for Disease
Control and Prevention, 3311 Toledo
Road, Room 2339, Hyattsville, Maryland
20782, telephone (301) 458–4614 or
Maya Bernstein, ASPE/OSDP, Room
436E, Department of Health and Human
Services, 200 Independence Avenue
SW., Washington, DC 20201, Phone:
(202) 690–5896. Program information as
well as summaries of meetings and a
roster of committee members are
available on the NCVHS home page of
the HHS Web site: https://
www.ncvhs.hhs.gov/, where further
information including an agenda will be
posted when available.
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment
Opportunity on 770–488–3204 as soon
as possible.
Dated: April 15, 2015.
James Scanlon,
Deputy Assistant Secretary for Planning and
Evaluation, Science and Data Policy, Office
of the Assistant Secretary for Planning and
Evaluation .
[FR Doc. 2015–09187 Filed 4–20–15; 8:45 am]
tkelley on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4151–05–P
6001 Executive Blvd., Rockville, MD
20852 or call this non-toll-free number
(301) 443–6504 or email your request,
including your address to: hperl@
nida.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Proposed Collection: Assessing an
Online Process to Study the Prevalence
of Drugged Driving in the U.S:
Development of the Drugged Driving
Reporting System, 0925–New, National
Institute on Drug Abuse (NIDA),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The study seeks to provide
an improved understanding of the
prevalence of drugged driving among
adult drivers in the U.S and will assess
the effectiveness of the online survey
implementation process. The primary
objectives of the study are to: (a) To
provide comprehensive data on drugged
driving; (b) determine if the Drugged
Driving Survey Instrument (DDS) is an
effective and accurate measure of
drugged driving among licensed U.S.
Drivers aged 18 and older. and, (c) to
assess the effectiveness of the survey
implementation process, including
various levels of incentives for
participation to determine the
appropriate/optimal incentive amount
needed to obtain the desired number of
total survey respondents within the
timeframe within which survey data
will be collected. The findings will
provide valuable information
concerning various aspects of substance
use and driving behavior, including: (1)
Demographic information about drivers
who do and do not drive while impaired
by medication and/or drugs (e.g. age, zip
code, type of driver’s license); (2) which
drugs/medications are most likely to be
used while driving; (3) drivers’ beliefs
and attitudes toward drugged driving.
OMB approval is requested for 2
years. There are no costs to respondents
other than their time. The total
annualized estimated burden hours are
750.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Assessing an
Online Process To Study the
Prevalence of Drugged Driving in the
U.S.: Development of the Drugged
Driving Reporting System (NIDA)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on November 24,
2014, page 69864 and allowed 60 days
for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Institute on Drug Abuse
(NIDA), the National Institutes of
Health, may not conduct or sponsor,
and the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact the NIDA Contract
Officer’s Representative (COR) Harold
Perl, Ph.D., Chief, Prevention Research
Branch, Division of Epidemiology,
Services & Prevention Research, NIDA,
SUMMARY:
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Type of respondent
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hours
Drugged Driving Survey ..................................
Adults .................................
3,750
1
12/60
750
VerDate Sep<11>2014
18:07 Apr 20, 2015
Jkt 235001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
E:\FR\FM\21APN1.SGM
21APN1
Agencies
[Federal Register Volume 80, Number 76 (Tuesday, April 21, 2015)]
[Notices]
[Pages 22209-22210]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-09187]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Committee on Vital and Health Statistics: Meeting;
Privacy, Security & Confidentiality Subcommittee
Pursuant to the Federal Advisory Committee Act, the Department of
Health and Human Services (HHS) announces the following advisory
committee meeting.
Name: National Committee on Vital and Health Statistics (NCVHS)
Subcommittee on Privacy, Confidentiality & Security.
Time And Date: May 6, 2015 9:00 a.m.-5:00 p.m. EST, May 7, 2015
9:00 a.m.-12:00 p.m. EST.
Place: U.S. Department of Health and Human Services, Centers for
Disease
[[Page 22210]]
Control and Prevention, National Center for Health Statistics, 3311
Toledo Road, Auditorium B and C, Hyattsville, Maryland 20782, (301)
458-4125.
Status: Open.
Purpose: Section 1179 of the Health Insurance Portability and
Accountability Act (HIPAA) creates an exemption from compliance with
HIPAA and accompanying rules when a financial institution is ``engaged
in authorizing, processing, clearing, settling, billing, transferring
or collecting payments.'' The purpose of this meeting is to learn how
banking and other financial service businesses are using personal
health data as their services evolve in support of the health industry.
The objectives of this hearing are as follows:
Increase awareness of current and anticipated financial services
involving personal health data, understand section 1179 in light of
these practices, and identify areas where outreach, education,
technical assistance, or guidance may be useful.
Contact Person For More Information: Debbie M. Jackson, Acting
Executive Secretary, NCVHS, National Center for Health Statistics,
Centers for Disease Control and Prevention, 3311 Toledo Road, Room
2339, Hyattsville, Maryland 20782, telephone (301) 458-4614 or Maya
Bernstein, ASPE/OSDP, Room 436E, Department of Health and Human
Services, 200 Independence Avenue SW., Washington, DC 20201, Phone:
(202) 690-5896. Program information as well as summaries of meetings
and a roster of committee members are available on the NCVHS home page
of the HHS Web site: https://www.ncvhs.hhs.gov/, where further
information including an agenda will be posted when available.
Should you require reasonable accommodation, please contact the CDC
Office of Equal Employment Opportunity on 770-488-3204 as soon as
possible.
Dated: April 15, 2015.
James Scanlon,
Deputy Assistant Secretary for Planning and Evaluation, Science and
Data Policy, Office of the Assistant Secretary for Planning and
Evaluation .
[FR Doc. 2015-09187 Filed 4-20-15; 8:45 am]
BILLING CODE 4151-05-P